Viewing Gene With Clinical Trials Data

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Report Bug Request Feature
Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol: NAV3
Name: neuron navigator 3
Location: 12q21.2
Locus Group: protein-coding gene
Gene Type: Protein Coding
Locus Type: gene with protein product
ID+ Clinical Trials CompTox DrugMatrix Conditions Design Enrollment Locations Outcomes
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all

Clinical Studies

NCT Number Status Brief Title View
NCT02683421 Evaluation of SC Injected Tc 99m Tilmanocept Localization in Active RA Subjects by SPECT and SPECTCT Imaging View
NCT02857608 A Prospective Open-Label Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identified Lymph Nodes of Subjects With Known Cancer of the Anus View
NCT04078191 Comparison of Tc 99m Tilmanocept Imaging With IHC Analysis of CD206 Expression in Synovial Tissue of Subjects With RA View
NCT05246280 Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFα Therapy Response in Moderate to Severe Active RA View
NCT02201420 Evaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposis Sarcoma and Lymphatic Drainage by SPECTCT View
NCT02509585 A Trial of Comparing the Pathology Status of Lymphoseek-Identified Sentinel Lymph Nodes Relative to the Pathological Pathology Status of Nonsentinel Lymph Nodes in Nodal Staging of Subjects With Known Cancer of the Cervix Who Are Undergoing Lymph Node Dissection View
NCT03332940 An Evaluation of the Safety of Intravenous Tc 99m Tilmanocept and a Comparison of Imaging With Sulfur Colloid in Subjects With and Without NASH View
NCT03241446 Pharmacokinetics and Dosimetry of Tc 99m Tilmanocept Following a Single Intravenous Dose Administration in Male and Female Subjects Diagnosed With Rheumatoid Arthritis RA View
NCT02509598 A Study of Lymphoseek as a Lymphoid Tissue Targeting Agent in Pediatric Patients With Melanoma Rhabdomyosarcoma or Other Solid Tumors Who Are Undergoing Lymph Node Mapping View
NCT02865434 Evaluating Safety of Escalating Doses of Tilmanocept by IV Injection and SPECT Imaging in Subjects With and Without RA View
NCT03029988 An Evaluation of Tilmanocept by IV Injection Using SPECTCT vs PET Imaging in Subjects With Liver Metastases View
NCT03157167 An Evaluation of Tc 99m Tilmanocept by Intravenous IV and Subcutaneous SC Injection in Kaposi Sarcoma KS View
NCT03938636 Evaluation of the Precision and Sensitivity of Tilmanocept Uptake Value TUV on Tc 99m Tilmanocept Planar Imaging View
NCT05639036 Image Guided EVD Placement View
NCT04947137 Development of a Normative Database for Rheumatoid Arthritis RA Imaging With Tc99m Tilmanocept View